Answers are grounded in this paper and cite their sources.
A patient, previously described, was found to have increased susceptibility to bacterial infections related to a deficiency of serum enhancement of in vitro phagocytosis. The same deficiency affected the patient's mother and 15 other relatives. The deficiency was shown to involve a dysfunction of the fifth component of complement (C5) by the fact that the phagocytosis-enhancing activity of the mother's serum was restored to normal by the addition of highly purified C5. Also, serum from mice with a genetic deficiency of C5 indicated poor enhancement of phagocytosis, and the addition of highly purified C5 to the Co-deficient mouse serum restored phagocytosis-enhancing activity. Finally, the addition of C5-deficient mouse serum to the mother's serum failed to improve the phagocytosis-enhancing effect of the maternal serum, whereas the addition of small amounts of normal mouse serum did. In view of the patient's clinical susceptibility to primarily gram-negative bacteria, the in vitro dysfunction of C5 may be related to impaired in vivo inactivation of such organisms.
No takes yet. Share an insight, caveat, or question.
Michael E. Miller (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: